This short review aims to explore the role of MD2 in stroke pathophysiology, its contribution to neuroinflammation and neuronal death, and the potential therapeutic strategies targeting MD2 to mitigate stroke-induced brain damage. This evidence concerns the gene LY96 and stroke disorder.